Pharmaceutical formulation of apomorphine for buccal administration
AssigneeAmarin Pharmaceuticals Ireland Limited
InventorAnthony Clarke
Life of this patent
Estimating the term…
Abstract
The present invention provides a kit comprising, in separate compartments of a container, the following components (a) and (b): (a) a combination of apomorphine or a pharmaceutically acceptable acid addition salt thereof and a pharmaceutically acceptable excipient or carrier; and (b) a solution which comprises a diluent and a pH modifying agent; the components being presented such that they can be combined at the point of use into a formulation which is adjusted to a pH ranging from mildly acidic to alkaline and which is suitable for buccal administration. The formulation is useful in treating Parkinson's disease and in promoting sexual function.
Claims5
A method of buccally administering an apomorphine composition to a patient in need thereof, comprising:
- (a) at the time of administration, adding a diluent and a pH modifying agent to an apomorphine composition to form a liquid composition comprising a pharmaceutically effective amount of apomorphine or a pharmaceutically acceptable acid addition salt thereof and a pharmaceutically acceptable excipient or carrier and to adjust the pH of the liquid composition to a pH ranging from mildly acidic to alkaline, thereby forming a pH adjusted liquid composition;
- and then
- (b) introducing the resulting pH adjusted liquid composition to the mouth of a patient in need thereof, thereby buccally administering a pharmaceutically effective amount of apomorphine or a pharmaceutically acceptable acid salt thereof.
Dependencies are inferred from the claim text.